Navigation Links
Will genomics help prevent the next pandemic?
Date:10/26/2009

This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomicswith all its associated tools and techniquescan provide insights into our understanding of emerging infectious disease.

As pandemic H1N1 2009 influenza (commonly referred to as swine flu) continues to spread around the globe, people want to know if this flu poses more of a threat than other seasonal flu strains, how fast it's spreading (and where), and what can be done to contain it. The increasing speed at which complete genome sequences and other genome-scale data can be generated provides tremendous opportunities to address these questions by identifying the molecular changes in disease agents such as influenza viruses that will enable us to track their spread and evolution and to generate the vaccines and drugs necessary to combat them. The "Genomics of Emerging Infectious Disease" collection discusses the challenges involved and how scientists and public health professionals might take advantage of these opportunities and advances to prevent the next pandemic. (See the link at the bottom of the release for a press preview PDF containing all the a rticles in the collection;.when the embargo ends the collection will be available at http://ploscollections.org/emerginginfectiousdisease/)

Emerging infectious diseases are caused by a wide range of organisms, but they are perhaps best typified by zoonotic viral diseases, which cross from animal to human hosts and can have a devastating impact on human health. These zoonotic diseases include monkeypox, Hendra virus, Nipah virus, and severe acute respiratory syndrome coronavirus (SARS-CoV), in addition to influenza A and the lentiviruses (HIV) that cause AIDS. As Albert Osterhaus and colleagues from the Erasmus Medical Center, Rott
'/>"/>

Contact: Liz Allen
lallen@plos.org
415-624-1218
Public Library of Science
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
3. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
4. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
5. NeoGenomics Announces Results for the 3rd Quarter 2007
6. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
7. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
8. NIH announces new initiative in epigenomics
9. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
10. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
11. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... York, New York (PRWEB) September 16, 2014 ... DePuy Pinnacle hip replacement lawsuit ( http://www.consumerinjurylawyers.com/depuy-pinnacle/lawsuit ) ... District of Texas has moved into its third ... documents, this week’s witnesses included a DePuy Orthopaedics ... company performed on the metal-on-metal Pinnacle hip. * ...
(Date:9/16/2014)... REDWOOD CITY, CALIF. (PRWEB) September 16, 2014 ... contact center and customer service solutions, announced today ... Group Excellence in Learning Award for the creation ... for independent contractor agents. Brandon Hall Group honors ... strategies, modalities, processes, systems and tools that have ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Regulatory ... available regulatory information, has become a crucial skill ... device and biotechnology sectors. Regulatory Intelligence 101 ... Society (RAPS) serves as an essential guide ... Regulatory Intelligence 101 examines available regulatory intelligence tools, ...
(Date:9/16/2014)... that replicates Ebola outbreaks can no longer be used ... finds research conducted by the University of Warwick. , ... developed a model that incorporated data from past outbreaks ... research, titled Epidemiological Dynamics of Ebola Outbreaks and published ... available data from the ongoing 2014 outbreak to the ...
(Date:9/16/2014)... 16, 2014) The Columbia University College of ... Education Excellence in Diversity (HEED) award from INSIGHT ... publication in higher education. As a recipient of ... colleges and universities that demonstrate an outstanding commitment ... with 82 other recipients in INSIGHT Into Diversity ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:RAPS Publishes Regulatory Intelligence 101 Book 2Health News:Ebola outbreak 'out of all proportion' and severity cannot be predicated 2Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4
... is a form of cancer where the plasma cells in ... bones as well as predisposing patients to anemia, infection and ... cell transplantation, commonly known as a stem cell transplant, is ... Unfortunately, multiple myeloma continues to progress even after a ...
... Serena Gordon HealthDay Reporter , FRIDAY, May 11 ... or slow the progression of type 1 diabetes in mice, ... to say if the results might apply to humans, however. ... system,s response to newly developing diabetes, and reduced the risk ...
... heart failure are more closely tied to the availability ... patients, degree of illness, according to research presented at ... Research Scientific Sessions 2012., U.S. regional readmission rates for ... 32 percent ― researchers found. Communities with higher rates ...
... outlive males, a circumstance that is usually attributed to ... they compete for females. This might also explain why ... burden than females. Therefore, high variability of immune genes, ... important for males. Scientists at the Research Institute of ...
... 10 (HealthDay News) -- Inducing labor after a woman has ... infant,s risk of death before, during or shortly after birth ... says. However, babies born after induced labor were also ... care unit, said researchers led by Sarah Stock of the ...
... cancer and a low haemoglobin (Hb) level do not respond ... and disease-free survival are compromised. Now researchers from The Netherlands ... these patients can be overcome by the use of a ... combined with carbogen (a mixture of carbon dioxide and oxygen) ...
Cached Medicine News:Health News:Study shows benefit of new maintenance therapy for multiple myeloma 2Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 2Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 3Health News:Hospital readmission rates linked to availability of care, socioeconomics 2Health News:Living longer - variability in infection-fighting genes can be a boon for male survival 2Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2Health News:Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels 2Health News:Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels 3
(Date:9/16/2014)... QPID Health , a leader in clinical intelligence software, today ... and their first West Coast location in San ... in Boston , and will house product development, ... Southern California office will be located at 1000 ... demands of customers nationwide.  Both new locations will be operational ...
(Date:9/16/2014)... 16, 2014   Evana Automation Specialists , a ... and test systems, recently received a contract to provide ... manufacturer. The Evana solution will help error-proof the process ... well as reduce labor. A catheter ... robotic assembly cell. The robot will pick the adapter, ...
(Date:9/16/2014)... ORLANDO, Fla. , Sept. 16, 2014   ... standard in the patient experience at hospitals. The myComfort™ ... , Vestagen,s active barrier fabric that is fluid repellant, ... shown to inhibit the growth of bacteria on the ... the role clothing plays in the chain of transmission. ...
Breaking Medicine Technology:QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2
... (OTC Bulletin Board: ACUR) (the "Company") today announced ... "Agreement"), with an,investor group comprised of Vivo Ventures ... L.P., GCE Holdings LLC and certain individual investors,(the ... Units ("Units") at a price of $1.08 per ...
... 20 Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned ... RLL has received approval from the U.S. Food ... and,Acetaminophen Tablets USP, 7.5 mg/750 mg, 10 mg/500 ... The Office of Generic Drugs, U.S. Food and ...
Cached Medicine Technology:Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 2Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 3Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP 2
... Battery Powered Orthopedic Systems., ,The PowerPro® ... to the Hall® Surgical line of powered ... the first and only software controlled battery ... is a full-function orthopedic power system specifically ...
... Brasseler USAs Large Bone Power System is ... new technological advancements. The truly innovative design ... pack, which is comprised of the battery, ... contains only mechanical components, which provides a ...
... is a type I collagen implant designed ... or loss of meniscus tissue, typically through ... purpose of the CMI is to assist ... a more vigorous lifestyle, while forestalling or ...
... OBIs proprietary PolyGraft® material technology which ... that is both biologically friendly and ... of polylactide-co-glycolide, calcium sulfate and polyglycolide ... fabricated into products such as granules, ...
Medicine Products: